Sage Journals: Discover world-class research

Retricted access

Other

First published 2006-8

A Novel Mutation in ALK-1 Causes Hereditary Hemorrhagic Telangiectasia Type 2

Z.M. Yan, Z.P. Fan, J. Du [...]

Journal of Dental Research

Open access

Case report

First published 2019-4

Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension

N Sommer, F Droege, KE Gamen [...]

Pulmonary Circulation

Retricted access

Research article

First published 2014-8

Napsin-A,TTF-1,EGFR,and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas

Giulio Rossi, Alberto Cavazza, Luisella Righi [...]

International Journal of Surgical Pathology

Retricted access

Research article

First published 2013-6

Toward Personalized Medicine of Lung Cancer

Paul H. Hartel, James V. Hartel, Julie C. Fanburg-Smith [...]

International Journal of Surgical Pathology

Open access

Research article

First published 2020-12

Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases

Mingming Hu, Tongmei Zhang, Yuan Yang [...]

The International Journal of Biological Markers

Retricted access

Research article

First published 2012-8

Detection of ALK fusion in lung cancer using fluorescence in situ hybridization

Masashi Kobayashi, Makoto Sonobe, Tsuyoshi Takahashi [...]

Asian Cardiovascular and Thoracic Annals

Retricted access

Case report

First published 2019-7

A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma

Barbara M Parker, John V Parker, Anastasios Lymperopoulos [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2016-4

Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

Meghan Shea, Daniel B. Costa, Deepa Rangachari

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2024-03-19

Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR,ALK and ROS1 tyrosine kinase inhibitors: An update

Joanna Moes-Sosnowska, Adam Szpechcinski, Joanna Chorostowska-Wynimko

Tumor Biology

Retricted access

Research article

First published 2022-2

Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples

Aslıhan Gürün Kaya, Aydın Çiledağ, Serhat Erol [...]

Scottish Medical Journal

Search results